The ESR in the diagnosis and management of the polymyalgia rheumatica/giant cell arteritis syndrome.
Open Access
- 1 April 1983
- journal article
- research article
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 42 (2), 168-170
- https://doi.org/10.1136/ard.42.2.168
Abstract
A review of 80 patients with the polymyalgia rheumatica/giant cell arteritis (PMR/GCA) syndrome has revealed that the erythrocyte sedimentation rate (ESR) is normal in 22.5% of cases at presentation. Too much reliance on the ESR as a screening test led to delay in diagnosis in 10 patients. Serious complications occurred in 4 patients with a normal or minimally raised ESR. Analysis of follow-up data at 4 weeks showed no significant correlation between change in the ESR and change in symptoms, and at subsequent clinical attendances symptoms did not consistently parallel the ESR. Our results cast serious doubts on the use of the ESR as an entirely reliable diagnostic and therapeutic aid in the PMR/GCA syndrome.This publication has 15 references indexed in Scilit:
- I. Persistently High Erythrocyte Sedimentation RateActa Medica Scandinavica, 2009
- Prognosis and management of polymyalgia rheumatica.Annals Of The Rheumatic Diseases, 1981
- Prognosis in giant-cell arteritis.BMJ, 1981
- Giant cell (cranial) arteritis: a clinical reviewAmerican Heart Journal, 1980
- Temporal ArteritisAnnals of Internal Medicine, 1978
- Polymyalgia Rheumatica and Giant Cell ArteritisArthritis & Rheumatism, 1971
- Normal erythrocyte sedimentation rate and age.BMJ, 1967
- THERAPEUTIC HAZARDS OF PHENYLBUTAZONE AND OXYPHENBUTAZONE IN POLYMYALGIA RHEUMATICAThe Lancet, 1967
- Articular and vascular manifestations of polymyalgia rheumatica.Annals Of The Rheumatic Diseases, 1967
- Polymyalgia RheumaticaActa Medica Scandinavica, 1965